Table 1 Demographics and ocular characteristics among PACG, NTG, and Controls.

Subjects (n)

51

48

49

N/A

N/A

N/A

Eyes (n)

68

68

68

N/A

N/A

N/A

Sex (female/male)

35/16

27/21

33/16

0.218

0.891

0.277

Age at recruitment (year)

59.82 ± 0.91

62.42 ± 1.30

59.42 ± 1.15

0.100

0.783

0.083

SE (diopter)

0.14 ± 0.22

−1.35 ± 0.32

−1.20 ± 0.27

 < 0.001

 < 0.001

0.720

AL (mm)

22.43 ± 0.12

24.60 ± 0.17

24.26 ± 0.15

 < 0.001

 < 0.001

0.138

IOP (mmHg) (range)

16.76 ± 0.52

(7.5–24.0)

14.65 ± 0.38

(10.0–20.0)

14.07 ± 0.33

(10.0–21.0)

0.001

 < 0.001

0.259

CCT (μm)

542.97 ± 4.52

531.54 ± 4.18

539.06 ± 5.06

0.063

0.564

0.252

BCVA

0.84 ± 0.03

0.95 ± 0.02

1.02 ± 0.02

0.003

 < 0.001

0.003

ACD (mm)

2.48 ± 0.06

3.22 ± 0.08

3.52 ± 0.31

 < 0.001

0.001

0.357

SAP MD (dB) (range)

−1.44 ± 0.24

(−5.73–1.17)

−1.55 ± 0.20

(−4.92– 1.65)

0.53 ± 0.08

(−1.82–1.96)

0.745

 < 0.001

 < 0.001

SAP PSD (dB) (range)

2.69 ± 0.20

(1.04–9.67)

3.10 ± 0.23

(1.39–10.55)

1.54 ± 0.04

(0.89–2.62)

0.172

 < 0.001

 < 0.001

SAP VFI (%) (range)

96.54 ± 0.56

(81–100)

96.30 ± 0.40

(82–100)

99.49 ± 0.08

(97–100)

0.721

 < 0.001

 < 0.001

Number of glaucoma medications

1.14 ± 0.13

0.82 ± 0.12

0

0.066

 < 0.001

 < 0.001